Alert: Brilique 90mg Tablets

Dispensary teams are alerted to a spelling error on G Pharma imported Brilique 90mg Tablets.

Cartons in three batches misspell the active ingredient as ‘Tricagelor’ rather than ‘Ticagrelor’.

The correct spelling of the active ingredient is included in the patient information leaflet and printed on the blister foil within the packs.

Patients should continue to take medicines from the impacted batches as prescribed. Batches are not being recalled.

For all medical information enquiries please email ddavies@gpharma.co.uk, or telephone 0161 888 7317. For stock control enquiries please email ddavies@gpharma.co.uk or telephone 0161 888 7317.

MHRA alert

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

Alert: Brilique 90mg Tablets

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association